IPO Premiums
IPO calendar
APANNUListed

Annu Projects Limited

Bookbuilding IPO · NSE, BSE

Price band
₹94 - ₹99
Lot size
151 shares
Issue amount
₹175.06 cr
Total subscription
2.93×
Current price₹38.79
Listing price ₹72
Watch live price ↗
Opens
25 Aug 2026
Closes
28 Aug 2026
Allotment
31 Aug 2026
Listing
2 Sept 2026

Offer at a glance

Issue overview

Issue size
1,76,83,000 shares
Face value
₹10 per share
Minimum investment
₹14,194
Fresh issue
₹175.06 cr
Offer for sale
₹0 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,949
Issue type
Bookbuilding IPO
Shares before issue
4,78,09,670
Shares after issue
6,98,09,670

Lot sizes

CategoryLotsSharesAmount
RETAIL1151₹14,949
sHNI142,114₹2,09,286
bHNI6710,117₹10,01,583

Share reservation

QIB10%
HNI40%
RETAIL50%

Subscription & GMP

Subscription by category

Total subscribed2.93×

Reported 28 Aug 2026

QIB1.72×
NIB3.55×
RETAIL2.68×
HNIs(10L+)3.09×
HNIs(2-10L)4.48×

GMP history

-70717 Apr: ₹019 Aug: ₹020 Aug: ₹022 Aug: ₹424 Aug: ₹324 Aug: ₹225 Aug: ₹126 Aug: ₹126 Aug: ₹427 Aug: ₹627 Aug: ₹5.527 Aug: ₹728 Aug: ₹129 Aug: ₹131 Aug: ₹11 Sept: ₹-51 Sept: ₹-62 Sept: ₹-71 Oct: ₹-7
17 Apr₹-71 Oct

Day-wise demand

25 Aug0.34×
26 Aug0.47×
27 Aug0.88×
28 Aug2.93×

Application-wise demand

CategoryReserved applicationsApplied applications
RETAIL58,5531,36,956
HNIs(10L +)2,2311,134
HNIs (2-10L)1,1154,031

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs17.5130.14
FIIs010
FIs05.17
Mutual Funds00.12
Others014.9
RETAIL87.53234.45
HNIs 2+23.34104.44
HNIs 10+46.69144.24

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
0100200300Mar-24 · Revenue: 155.4Mar-24 · Profit after tax: 17.38Mar-24Mar-25 · Revenue: 182.3Mar-25 · Profit after tax: 21.14Mar-25Mar-26 · Revenue: 244.5Mar-26 · Profit after tax: 33.02Mar-26
RevenueProfit after tax

Key performance indicators

MetricMar-26Mar-25Mar-24
EPS6.914.654.07
ROE000
ROCE000
RONW21.2717.2925.23
PRE IPO(PE)14.3300
POST IPO(PE)19.6400

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
Likhitha Infrastructure Limited23.17230.35104.479.379.94
Bondada Engineering Limited16.6303.5262.3528.8218.28
EMS Limited24.65401.7510190.038.6216.3
Suvgo Telematics Limited16.61881.21042.512.8854.7
Annu Projects Limited14.3399.001032.4821.276.91

Company information

Company profile

Founded in 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd. is a medical device company that focuses on advanced Class III and Class C/D devices used mainly in vascular and structural heart treatments. The company was the first in the world to receive CE certification for a drug-eluting stent with a biodegradable polymer called Infinnium. Its product range includes coronary stents and balloons for vascular interventions, technologies like TAVI and occluders for structural heart treatments, as well as renal stents and drug-coated balloons. The company operates R&D centres in India and Thailand and has a strong innovation base with over 100 granted patents and several pending applications. Its key products, including Supraflex Cruz, Hydra, and Cocoon, are supported by multiple clinical studies and are used in more than 76 countries. Sahajanand follows a global distribution strategy combining direct sales, hybrid models, and distributor partnerships across different markets. As of March 31, 2025, the company had over 1,400 employees along with consultants and contract staff supporting its operations.

Strengths

  • Integrated Utility Infrastructure Capabilities: The company handles engineering, procurement and commissioning projects for underground and overhead utility infrastructure across multiple key areas.
  • Integrated Project Execution: With strong project management and execution capabilities, the company can efficiently handle projects across different infrastructure segments.
  • Strong Order Book: A healthy order book provides good visibility for upcoming projects and supports future revenue growth.

Risk factors

  • Dependence on Telecom and Sewerage: More than 90% of the company’s revenue comes from telecom and sewerage projects. Any slowdown or lower demand in these sectors could negatively affect the business.
  • Dependence on Government Projects: A significant portion of revenue comes from government customers through competitive bidding. Failure to win new government projects could impact revenue and financial performance.
  • High Customer Concentration: Most of the company’s revenue comes from its top 10 customers. Losing a major customer or a decline in their orders could negatively affect revenue, cash flow and overall business performance.

Promoters

Sanjay Kumar Sarraf

Krishna Ranjan

Registrar & documents

Lead manager

Mefcom Capital Markets Limited

Registered office

Annu Projects Ltd. B-1, Plot No. 11, Local Shopping Complex Vasant Kunj, South Delhi, New Delhi, 110070

+91 11 40114238

[email protected]Company website ↗

Understanding ANNU IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.